USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$18.84M
Market Cap
-
P/E Ratio
-20
EPS
$39.75
52 Week High
$6.27
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | - |
| Total Revenue | $0 |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$17M |
| Selling General And Administrative | $6.2M |
| Research And Development | $11M |
| Operating Expenses | $17M |
| Investment Income Net | - |
| Net Interest Income | -$77K |
| Interest Income | - |
| Interest Expense | $77K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | -$20B |
| Income Before Tax | $2.8M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $2.8M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $2.7B |
| Ebitda | $2.9M |
| Net Income | $2.8M |
| Field | Value (USD) |
|---|---|
| Gross Profit | - |
| Total Revenue | $0 |
| Cost Of Revenue | - |
| Costof Goods And Services Sold | - |
| Operating Income | -$17M |
| Selling General And Administrative | $6.2M |
| Research And Development | $11M |
| Operating Expenses | $17M |
| Investment Income Net | - |
| Net Interest Income | -$77K |
| Interest Income | - |
| Interest Expense | $77K |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | -$20B |
| Income Before Tax | $2.8M |
| Income Tax Expense | - |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $2.8M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $2.7B |
| Ebitda | $2.9M |
| Net Income | $2.8M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None